Who are the Leading Synthetic Cannabinoids Providers across the globe?

Synthetic Cannabinoids are anticipated to enter growth stage by mid-term forecast. Several biotech startups such as Emerald Health Pharmaceuticals, RespireRx etc are pioneering initiatives for the development of synthetic cannabinoid compounds which will augment the growth of synthetic cannabinoid market. On this backdrop, synthetic cannabinoids are projected to create an absolute dollar opportunity of US$ 89 Mn during forecast period.

Browse Full Report - https://www.factmr.com/report/4156/synthetic-cannabinoids-market

Dronabinol as a type of synthetic cannabinoid has maintained its lead in the market and is expected to experience higher growth rate vis-a-vis Nabilone. Dronabinol has superior investment backing which is boosting its uptake in the market.

A vast majority of the companies in synthetic cannabinoids market have been focusing on products which are in their clinical trial phase. For instance, TheraPix Biosciences, Tetra Bio-Pharma and Zynerba Pharmaceuticals are some of the companies that are conducting clinical trials for their compounds.

Other companies like GW Pharmaceuticals, Kannalife and FSD Pharma are developing synthetic cannabinoids. Such novel initiatives will enable manufacturers to expand their profit pools in the synthetic cannabinoids market.

Key Takeaways of Global Synthetic Cannabinoids Market

To remain ‘ahead’ of your competitors, request for a sample - https://www.factmr.com/connectus/sample?flag=S&rep_id=4156

Dronabinol type of synthetic cannabinoid accounts for more than 90% market share and is expected to witness a rising growth curve in synthetic cannabinoids owing to novel usage of drugs in several experimental therapies such as arthritis and cancer

Nabilone showcases a marginal contribution to global synthetic cannabinoids market and is projected to grow 4.5X over period of forecast 2019 – 2029, due to increased legal and pharmaceutical usage in United States, Canada and Europe.

North America synthetic cannabinoids market is projected to hold around two third of market share. However, Asia Pacific and Latin America are projected to grow at a higher CAGR than the global average.

Europe synthetic cannabinoids market is the second largest market and is anticipated to hold around 20% market share in terms of value and likely to gain 180 BPS over forecast period 2019 – 2029.

For critical insights on this market, request for methodology here – https://www.factmr.com/connectus/sample?flag=RM&rep_id=4156

The Synthetic Cannabinoids market report provides the readers with the below-mentioned insights:
• Key trends, including ecological conservation, patented solutions, and globalization.
• Consumption pattern of each segment of the market in every region.
• Detailed study of the factors (positive and negative) impacting the growth of the global Endobronchial Valves market.
• Critical analysis of R&D activities performed by market players to expand their production footprint across various industries.
• Thorough research of effect of the market across various end use industries.

To connect an Expert - https://www.factmr.com/connectus/sample?flag=AE&rep_id=4156

The Synthetic Cannabinoids market report gets rid of the following queries:
1. Which end use has the highest rate of consumption and why?
2. Which regions are the market players targeting to gain a competitive edge?
3. What is the growth forecast of the global market in region?
4. What is the Y-o-Y growth rate of the global market?
5. Which segment will have the maximum share of the global market by the end of year?
And so on…..

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),

Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com
Research Insight: https://www.factmr.com/report/4156/synthetic-cannabinoids-market
Content Source: https://www.factmr.com/media-release/1302/global-synthetic-cannabinoids-market

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

This release was published on openPR.